Reuters Health News Summary


Reuters | Updated: 07-03-2019 10:29 IST | Created: 07-03-2019 10:29 IST
Reuters Health News Summary

Following is a summary of current health news briefs. FDA finds asbestos in three Claire's cosmetics products

The U.S. Food and Drug Administration called on Congress to modernize rules for cosmetics safety on Tuesday after it issued an alert warning consumers not to use three cosmetics products sold by Claire's Stores Inc because they tested positive for asbestos, a known carcinogen. The FDA said it would work with Congress to update the regulatory framework that the agency has been operating under for more than 80 years for cosmetics. It said there are currently no legal requirements for any cosmetic manufacturer selling goods to American consumers to test their products for safety. U.S. FDA chief tough on e-cigarettes steps down abruptly

U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs. Gottlieb was well regarded by public health advocates and won bipartisan support for his efforts to curb use of flavored e-cigarettes by youths, speed approval times for cheap generic medicines to increase competition and bring down drug prices, and boost the use of cheaper versions of expensive biotech medicines called biosimilars. Women who vape around pregnancy may wrongly think it safe

Health professionals advise against using any nicotine products during pregnancy, but some women are using e-cigarettes before, during or after pregnancy and thinking it's safer than smoking, U.S. researchers report. In a survey of more than 3,000 new mothers in Oklahoma and Texas, 7 percent said they had used electronic vapor products, including e-cigarettes, around the time of their pregnancy; 1.4 percent used them during pregnancy. Aerobic exercise eases depression, even in chronically ill

People with chronic health problems who suffer from depression may find their mood improve when they do aerobic exercise, a research review suggests. Patients with long-term medical issues are two to three times more likely to develop depression than the general population, researchers noted in the British Journal of Sports Medicine, online February 6. When these patients do become depressed, their chronic illnesses often worsen and their risk of dying goes up. J&J prices ketamine-like depression treatment at $590-$885 for two doses

Johnson & Johnson said on Wednesday its nasal spray depression treatment, called Spravato, will be priced at $590 for a 56 mg dose and $885 for 84 mg. During the induction phase of the therapy, which lasts for a month, patients will be treated twice a week with either dose, resulting in a wholesale acquisition cost or list price in the range of $4,720 to $6,785, Janssen spokesman Greg Panico said in an email statement. Allergan depression treatment fails studies, shares slip

Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell. The failure comes as the company faces increasing pressure from activist shareholders such as billionaire hedge fund manager David Tepper, who has urged the drugmaker to consider selling itself. WHO chief unveils reforms, with more science, apps and an academy

The World Health Organization unveiled a landmark reform on Wednesday that targets billions of people around the globe and puts a stress on primary care for all rather than "moonshot" projects like eradicating diseases. The reform firmly reshapes the Geneva-based U.N. health agency with the manifesto of its Director-General Tedros Adhanom Ghebreyesus, an Ethiopian who is the first African in the job. He was elected in 2017 promising to focus on "universal health coverage" (UHC). Sinus problems tied to higher risk of depression, anxiety

People who suffer from a common chronic sinus disorder may be more likely than those who don't to develop depression and anxiety, a Korean study suggests. Researchers focused on chronic rhinosinusitis, which happens when the cavities around the nasal passages are inflamed and swollen for at least 12 weeks. Symptoms can include facial pain and headaches, nasal obstruction and an impaired sense of smell. World's second man cleared of AIDS virus invigorates quest for cure

Scientific investigation into the world's second man cleared of the AIDS virus is zooming in on a gene and a treatment side-effect, as newly-enthused researchers strive to find a cure for the disease that has killed millions. Known as the "London Patient", the man had HIV and a type of blood cancer called Hodgkin's lymphoma. He responded successfully to a bone marrow transplant from a donor with rare genetic resistance to HIV infection. U.S. bolsters 'Beagle Brigade' to sniff out deadly hog virus

The U.S. government will employ more dogs to sniff out illegal pork products at airports and seaports in an effort to keep out a contagious hog disease that has spread across Asia and Europe, the U.S. Department of Agriculture said on Wednesday. The disease, African swine fever, can kill hogs in just two days, but is not harmful to people. China, home to the world's largest hog herd, has reported more than 100 cases of the disease in 27 provinces and regions since August. Efforts to contain the fever have disrupted Chinese pork supplies.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback